Pinnbrook Capital Management LP Buys Shares of 81,200 Ventas, Inc. $VTR

Key Points

• Pinnbrook Capital Management purchased 81,200 Ventas shares during the second quarter, valued at approximately $7.2 million. Other institutions also initiated positions, and institutional investors now own 94.18% of the healthcare REIT.
• Analysts maintain a broadly positive outlook: 15 rate Ventas a Buy and three assign a Hold, producing a “Moderate Buy” consensus and an average price target of $98.
• Ventas reported quarterly EPS of $0.97, slightly above estimates, while revenue rose 21.7% year over year to $1.73 billion. The stock recently traded at $93.32, near its $101.60 52-week high.

Pinnbrook Capital Management LP bought a new stake in Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 81,200 shares of the real estate investment trust's stock, valued at approximately $7,211,000.

Other hedge funds also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Ventas during the second quarter worth about $3,838,000. Evolve Private Wealth LLC purchased a new position in shares of Ventas during the second quarter valued at approximately $328,000. Varma Mutual Pension Insurance Co purchased a new position in shares of Ventas during the second quarter valued at approximately $13,921,000. Westpac Banking Corp purchased a new position in shares of Ventas during the second quarter valued at approximately $8,973,000. Finally, Korea Investment CORP acquired a new stake in Ventas during the second quarter worth approximately $21,496,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have commented on VTR shares. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Raymond James Financial began coverage on Ventas in a research note on Tuesday, June 16th. They set an "outperform" rating and a $94.00 price target on the stock. Jefferies Financial Group raised their price objective on Ventas from $97.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, May 12th. UBS Group lifted their price objective on Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $100.00 target price on shares of Ventas in a research note on Tuesday, June 16th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Ventas has an average rating of "Moderate Buy" and a consensus target price of $98.00.

Ventas Price Performance

Ventas stock opened at $93.32 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The company has a market cap of $47.87 billion, a price-to-earnings ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. Ventas, Inc. has a 1 year low of $66.38 and a 1 year high of $101.60. The firm has a 50 day moving average price of $91.36 and a 200 day moving average price of $87.08.

Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business earned $0.87 EPS. Ventas's revenue for the quarter was up 21.7% on a year-over-year basis. Sell-side analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company's stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.53% of the company's stock.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source